EIF4EBP1 and hepatocellular carcinoma: Specifically, a study in HCC patients undergoing orthotopic liver transplantation reported mTOR pathway to be active in 40% of the patients, but none of the biomarkers [PTEN, p-AKT, p-mTOR, p-p70S6K and p-4EBP-1] were associated with survival [43].